Rheumatology News & Perspectives

EMA Releases New Guide on Biosimilar Medicine

Written on 16 May 2017. Posted in Rheumatology News & Perspectives

The European Medicines Agency (EMA) and the European Commission have published a new guide on biosimilars for health professionals. Biosimilars are biological medicines…

Reference: New guide on biosimilar medicines for healthcare professionals, ema.europa.eu

AAOS: Glucosamine Sulfate and Intraarticular HA Ineffective for Hip Osteoarthritis

Written on 25 April 2017. Posted in Rheumatology News & Perspectives

The American Academy of Orthopedic Surgeons (AAOS) has recently published new clinical practice guidelines (CPG) for the treatment of hip osteoarthritis. The guidelines do not support the…

Rheumatoid Arthritis: Adjustment of CRP and ESR to the Patients' BMI

Written on 19 April 2017. Posted in Rheumatology News & Perspectives

CRP or erythrocyte sedimentation rate (ESR) measurements are widely used to evaluate the disease activity of rheumatoid arthritis (RA) in clinical research and in daily practice. It is…

Back Pain Is Not as Harmless as Believed and Could Raise Mortality

Written on 21 March 2017. Posted in Rheumatology News & Perspectives

According to a study published in the European Journal of Pain, patients with spinal pain (i.e. low back and neck pain) could be at higher risk of all-cause and disease-specific…

Less Myocardial Infarction in RA Patients Treated with TNF inhibitors

Written on 18 March 2017. Posted in Rheumatology News & Perspectives

In meta-analyses, patients with rheumatoid arthritis (RA) have an increased risk of myocardial infarction (MI) by 60% compared to the general population and an increased incidence of death…

Menopause and Risk of Seronegative Rheumatoid Arthritis

Written on 04 March 2017. Posted in Rheumatology News & Perspectives

Genetic and environmental risk factors have been long identified as promoting the occurrence and development of rheumatoid arthritis (RA) phenotypes associated with anti-citrullinated…

No Benefits for Intensive over Symptomatic Bisphosphonate Treatment in Paget's Disease

Written on 19 February 2017. Posted in Rheumatology News & Perspectives

“Long-term intensive bisphosphonate treatment does not confer any clinical benefit over symptomatic treatment and is associated with a non-significant increase in the risk of…